Diamond Drugs Inc. – FDA Inspection, Jul 21, 2017

Record Details

This FDA Inspection record concerns Diamond Drugs Inc., with an inspection on July 21, 2017, issued by the Philadelphia District Office, covering human drugs.

Company: Diamond Drugs Inc.
Inspection Date: July 21, 2017
Product Type: Human Drugs
Office: Philadelphia District Office
Person: Nancy F. Scheraga (FDA Associated Person)

View Company Profile

ID · 3d19655c-c9d6-46e1-84de-c40a4f87acdb

Inspection Facts

Inspection number: 1018898
FDA center: Human Drugs
Outcome: Form 483 issued

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Diamond Drugs Inc.

FDA Inspection

Diamond Drugs Inc.July 21, 2017

Diamond Drugs Inc. – FDA Inspection, Jul 21, 2017

Record Details

This FDA Inspection record concerns Diamond Drugs Inc., with an inspection on July 21, 2017, issued by the Philadelphia District Office, covering human drugs.